Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Design of the SARS-CoV-2 RBD vaccine antigen improves neutralizing antibody response

Science Advances(2022)10.1126/sciadv.abq8276Source: DataRank Database

Design of the SARS-CoV-2 RBD vaccine antigen improves neutralizing antibody response is a research paper published in Science Advances (2022). On theSindex it has a DataRank of 0. It has been cited 57 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access57 citations

Download PDF

Cite:

Linked data & code

gen pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 5.28)OA: goldTopics (29)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Wai Kwan Tang ORCID,Brandi Butler ORCID,Tarik Ouahes,Sachy Orr-Gonzalez,Nichole D. Salinas ORCID

Live enrichment

PubMed:36103542 PMC:PMC9473567 OpenAlex:https://openalex.org/W4295904951

NIH HHS

Grant: S10 OD012289

FWCI

5.28

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: other-oa

journalhttps://doi.org/10.1126/sciadv.abq8276

publisherhttps://doi.org/10.1126/sciadv.abq8276

publisherhttps://www.science.org/doi/pdf/10.1126/sciadv.abq8276

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36103542

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9473567

Fields of Study

SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approachesImmunotherapy and Immune ResponsesAmino AcidsAntibodies, NeutralizingCOVID-19COVID-19 VaccinesHumansSARS-CoV-2Spike Glycoprotein, CoronavirusViral Vaccines

MeSH Terms

COVID-19SARS-CoV-2COVID-19 VaccinesAmino AcidsHumansViral VaccinesAntibodies, NeutralizingSpike Glycoprotein, Coronavirus

Keywords

Neutralizing antibodyVirologyAntibodyEpitopeNeutralizationImmune systemBiologyAntigenAntibody responseImmunology

Sustainable Development Goals

SDG 0: Good health and well-being